Diagnostic endoscopic retrograde cholangiopancreatography

Endoscopy

Volumn 31, Issue 1, 1999, Pages 74-79

  Shimizu, S ^a   Kutsumi, H ^b   Fujimoto, S ^b   Kawai, K ^b  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; METHYLPREDNISOLONE;

COMMON BILE DUCT STONE; CYTOLOGY; DIAGNOSTIC ACCURACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL DISEASE; HISTOLOGY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREATITIS; PRIORITY JOURNAL; REVIEW;

BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; PANCREATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 0032973542     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-13651     Document Type: Review

References (38)

1. Johnson GK, Geenen JE, Johanson JF, et al. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreatobiliary Study Group. Gastrointest Endosc 1997; 46: 217-22
2. 1-antitrypsin complex values identify endoscopic retrograde cholangiopancreatography-induced pancreatitis with high accuracy. Gut 1997; 41: 690-5
3. Bordas JM, Toledo-Pimental V, Llach J, et al. Effect of somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc 1998; 47: 230-4
4. Dumot JA, Darwin DO, Conwell L, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998; 93: 61-5
5. Fulcher AS, Turner MA, Capps GW, et al. Half-Fourier RARE cholangiopancreatography: experience in 300 subjects. Radiology 1998; 207: 21-32
6. Bearcroft PW, Gimson A, Lomas DJ. Non-invasive cholangiopancreatography by breath-hold magnetic resonance imaging: preliminary results. Clin Radiol 1997; 52: 345-50
7. Chrysikopoulos H, Papanikolaou N, Pappas J, et al. MR cholangiopancreatography at 0.5 T with a 3D inversion recovery turbo-spin-echo sequence. Eur Radiol 1997; 7: 1318-22
8. Irie H, Honda H, Tajima T, et al. Optimal MR cholangiopancreatographic sequence and its clinical application. Radiology 198; 206: 379-87
9. Lomonto D, Pavone P, Laghi A, et al. Magnetic resonance cholangiopancreatography in the diagnosis of biliopancreatic disease. Am J Surg 1997; 174: 33-8
10. Yamaguchi K, Chijiiwa K, Shimizu S, et al. Comparison of endoscopic retrograde and magnetic resonance cholangiopancreatography in the surgical diagnosis of pancreatic diseases. Am J Surg 1998; 175: 203-8
11. Catalano C, Pavone P, Laghi A, et al. Pancreatic adenocarcinoma: combination of MR imaging, MR angiography and MR cholangiopancreatography for the diagnosis and assessment of resectability. Eur Radiol 1998; 8: 428-34
12. Ueno E, Takada Y, Yoshida I, et al. Pancreatic disease: evaluation with MR cholangiopancreatography. Pancreas 1998; 16: 418-26
13. Nicaise N, Pellet O, Metens T, et al. Magnetic resonance cholangiopancreatography: interest of IV secretin administration in the evaluation of pancreatic ducts. Eur Radiol 1998; 8: 16-22
14. Sugiyama M, Atomi Y, Hachiya J. Intraductal papillary tumors of the pancreas: evaluation with magnetic resonance cholangiopancreatography. Am J Gastroenterol 1998; 93: 156-9
15. Pavone P, Laghi A, Lomonto D, et al. MR cholangiography (MRC) in the evaluation of CBD stones before laparoscopic cholecystectomy. Surg Endosc 1997; 11: 982-5
16. Musella M, Barbalace G, Capparelli G, et al. Magnetic resonance imaging in evaluation of the common bile duct. Br J Surg 1998; 85: 16-9
17. Miyazaki T, Yamashita Y, Tang Y, et al. Single-shot MR cholangiopancreatography of neonates, infants, and young children. AJR Am J Roentgenol 1998; 170: 33-7
18. Yamataka A, Kuwatsuru R, Shima H, et al. Initial experience with non-breath-hold magnetic resonance cholangiopancreatography: a new noninvasive technique for the diagnosis of choledochal cyst in children. J Pediatr Surg 1997; 32: 1560-2
19. Adamek HE, Weitz M, Breer H, et al. Value of magnetic resonance cholangiopancreatography (MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1997; 29: 741-4
20. Mansfield JC, Griffin SM, Wadehra V, et al. A prospective evaluation of cytology from biliary strictures. Gut 1997; 40: 671-7
21. Sears RJ, Duckworth CW, Decaestecker C, et al. Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography. Cancer 1998; 84: 119-26
22. Furuya N, Kawa S, Akamatsu T, et al. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997; 113: 593-8
23. Tada M, Teratani T, Komatsu Y, et al. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma. Dig Dis Sci 1998; 43: 15-20
24. Iwao T, Harada K, Tsuchida A, et al. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations. Cancer 1998; 82: 1487-94
25. Rosen HR, Winkle PJ, Kendall BJ, et al. Biliary interleukin-6 and tumor necrosis factor-α in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997; 42: 1290-4
26. Lai KH, Peng NJ, Lo GH, et al. Prediction of recurrent choledocholithiasis by quantitative cholescintigraphy in patients after endoscopic sphincterotomy. Gut 1997; 41: 399-403
27. Neitlich JD, Topazian M, Smith RC, et al. Detection of choledocholithiasis: comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography. Radiology 1997; 203: 753-7
28. Kruis W, Roehrig H, Hardt M, et al. A prospective evaluation of the diagnostic work-up before laparoscopic cholecystectomy. Endoscopy 1997; 29: 602-8
29. Tham TCK, Lichtenstein DR, Vandervoort J, et al. Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Gastrointestinal Endosc 1998; 47: 50-6
30. Tajiri H, Kobayashi M, Ohtsu A, et al. Peroral pancreatoscopy for the diagnosis of pancreatic diseases. Pancreas 1998; 16: 408-12
31. Jung M, Zipf A, Schoonbroodt D, et al. Is pancreatoscopy of any benefit in clarifying the diagnosis of pancreatic duct lesions? Endoscopy 1998; 30: 273-80
32. Kaneko T, Nakao A, Nomoto S, et al. Intraoperative pancreatoscopy with the ultrathin pancreatoscope for mucin-producing tumors of the pancreas. Arch Surg 1998; 133: 263-7
33. Weston AP. Sincalide, a cholecystokinin agonist, as an aid in endoscopic retrograde cholangiopancreatography: a prospective assessment. J Clin Gastroenterol 1997; 24: 227-30
34. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 755-63
35. Harrel DJ, Vitale GC, Larson GM. Selective role for endoscopic retrograde cholangiopancreatography in abdominal trauma. Surg Endosc 1998; 12: 400-4
36. Shah SA, Movson J, Ransil BJ, et al. Pancreatic duct stricture length at ERCP predicts tumor size and pathological stage of pancreatic cancer. Am J Gastroenterol 1997; 92: 964-7
37. Van Gulik TM, Reeder JW, Bosma A, et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997; 46: 417-23
38. Tarnasky PR, Hoffman B, Aabakken L, et al. Sphincter of Oddi dysfunction is associated with chronic pancreatitis. Am J Gastroenterol 1997; 92: 1125-9